Tunstall Supports Countrywide Approach to Transform the Lives of Three Million People with Telehealthcare

Tunstall HealthcareLeading telehealth and telecare services provider, Tunstall Healthcare, is supporting a new approach that aims to transform the lives of three million people with long-term conditions or social care needs, utilising telehealth and telecare within health and social care services.

Launched yesterday by the Minister of State for Care Services, Paul Burstow MP, '3millionlives' will enable millions of people to receive the significant benefits derived from a recently completed telehealth and telecare pilot, known as the Whole Systems Demonstrator (WSD) programme. The Minister re-affirmed his commitment to working with industry to improve the lives of millions of people today by publishing a Concordat with the four trade associations representing the telehealth and telecare industry.

Care Services Minister Paul Burstow said: "This new approach is set to improve the quality of care for 3 million people, increase their independence and dignity as well as reduce the time they spend in hospital. It is only by the telehealth industry working together with the Department of Health and other stakeholders, that this will be possible. In addition, UK industry will gain a competitive edge in a marketplace where many millions of people worldwide could benefit from this technology, helping to generate income and jobs in the UK."

The WSD programme was established by the Department of Health (DH) to evaluate how the use of telehealth and telecare services can support people with long-term health and care needs to live more independently. The three-year research project aimed to create the largest evidence base for telehealth and telecare in the world. Key findings from the WSD programme include a 15% reduction in A&E visits, a 20% reduction in emergency admissions, a 14% reduction in elective admissions, and a 45% reduction in mortality rates.

Tunstall's telehealthcare services are being used extensively in the WSD programme and is the only company with systems deployed in all 3 WSD sites Cornwall, Kent and Newham. The company's services enable patients to monitor their vital signs in their own homes easily, safely and securely and aids proactive case management, ensuring timely and appropriate support to patients.

Gil Baldwin, Vice Chair of the 3millionlives working group and CEO of Tunstall, said: "3millionlives is a fantastic example of industry and government working alongside each other to improve the lives of individuals living with long term conditions, enhancing clinical outcomes, supporting patients and doctors and saving money for the tax payer."

'3millionlives' will develop appropriate ways for the market to engage with stakeholders and commission telehealthcare at scale, and increase awareness and visibility of the potential benefits of telehealth and telecare globally, generating significant opportunities for UK plc.

The 3millionlives website is now live, and anyone interested in finding out more or becoming involved can find details at www.3millionlives.co.uk

Related news articles:

About Tunstall
Tunstall Healthcare Group is the market leading provider of telehealthcare solutions, with over 2.5 million users globally. Tunstall's solutions support older people and those with long-term needs, helping them to live independently by effectively managing their health and well-being. Its solutions have been proven effective in the world's largest telehealthcare trial. Tunstall provides technology, expertise and advice to millions of people enabling them to lead independent more fulfilling lives.

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...